Da Bu Yin Wan (Great Tonify the Yin Pill)

Actions

Indications

Western Uses:

• What is Da Bu Yin Wan used for in modern practice?

  In modern practice Da Bu Yin Wan is referenced for conditions that present with the traditional yin-deficiency-fire pattern — night sweats, low-grade or afternoon fever, irritability, and heat sensations. Practitioners have traditionally applied this pattern to states such as menopausal hot flashes and night sweats, some presentations of hyperthyroidism/Graves’ disease marked by heat and sweating, and, in contemporary Chinese research, as a candidate herbal intervention studied for neuroprotective effects in Parkinson’s disease models.

  These biomedical correlates are offered as a reference to the formula’s traditional use, not as a claim that it treats any disease. Current research on Da Bu Yin Wan itself is preclinical — cell and animal studies of mitochondrial mechanisms (see research) — not human clinical trials. Any use for a diagnosed condition belongs with a qualified practitioner and appropriate medical care.

  Source: traditional-use correlates summarized from Bensky & Barolet, Formulas & Strategies; research correlate from PubMed (see research field). Reference only, not a treatment claim.

Originally Appeared In:

• Teachings of Dan Xi (Dan Xi Xin Fa)

Notes:

• How is Da Bu Yin Wan different from Zhi Bai Di Huang Wan and Zuo Gui Wan?

  Da Bu Yin Wan is distinguished by Gui Ban’s anchoring action, which gives it a stronger, more targeted ability to subdue vigorous deficiency fire than formulas built only around the Rehmannia-based yin tonics.

  • vs Zhi Bai Di Huang Wan (Liu Wei Di Huang Wan + Zhi Mu + Huang Bai): that formula nourishes yin across Kidney, Liver, and Spleen more broadly with a milder fire-clearing action; Da Bu Yin Wan is more concentrated on draining vigorous fire and, via Gui Ban, anchoring floating yang — choose it when fire signs (tidal fever, night sweats, irritability) are more pronounced.
  • vs Zuo Gui Wan: Zuo Gui Wan purely enriches Kidney yin and essence without draining fire, for yin deficiency with minimal heat signs; Da Bu Yin Wan is chosen instead when deficiency fire is vigorous.

  Preparation note: traditionally taken as pills bound with pig spinal marrow and honey (per the formula’s classic construction) rather than as a decoction, since prolonged simmering is not required for the fire-clearing action and the pill form moderates the bitter-cold deputies.

  Source: Bensky & Barolet, Formulas & Strategies (formula comparisons and traditional preparation).

Clinical Studies & Research:

• Is there modern research on Da Bu Yin Wan?

  Yes, but it is preclinical — cell and animal studies, mostly focused on Parkinson’s disease models, rather than human clinical trials. Several studies from Chinese research groups have examined Da-Bu-Yin-Wan (DBYW), alone or paired with the formula Qian-Zheng-San, for effects on mitochondrial function in neurotoxin-induced models of Parkinson’s disease — a modern mechanistic angle on a formula traditionally used for Liver/Kidney yin deficiency with rising fire (a pattern classically associated with tremor and internal wind).

  • Mitochondrial dysfunction (preclinical, cell model): DBYW augmented DJ-1-related Akt phosphorylation and improved mitochondrial dysfunction in a cellular Parkinson’s disease model (PMID 30405418; PMC 6200911).
  • Mitochondrial dynamics (preclinical, cell model): DBYW combined with Qian-Zheng-San improved mitochondrial mass, membrane potential, and fission/fusion protein expression (Drp1, Fis1, Parkin, Mfn1/2, OPA1) in an MPP+-induced cell model (PMID 31068806; PMC 6491701).
  • Neuroprotection (preclinical, mouse model): DBYW combined with Qian-Zheng-San showed neuroprotective effects via mitochondrial ATP-sensitive potassium channels in an MPTP-induced mouse model (PMID 25610480; PMC 4290155).

  Sources: PubMed 30405418 / PMC 6200911; PubMed 31068806 / PMC 6491701; PubMed 25610480 / PMC 4290155. Research context, not a therapeutic claim; all cited studies are preclinical (cell/animal), and none establish efficacy for any human disease.